报销
医学
糖尿病
糖尿病管理
护理部
医疗保健
2型糖尿病
经济增长
内分泌学
经济
作者
Joni Beck,Deborah A. Greenwood,Lori Blanton,Sandra T. Bollinger,Marcene K. Butcher,Jo Ellen Condon,Marjorie Cypress,Priscilla Faulkner,Amy Hess Fischl,Theresa Francis,Leslie E. Kolb,Jodi Lavin-Tompkins,Janice MacLeod,Melinda D. Maryniuk,Carolé Mensing,Eric A. Orzeck,David D. Pope,Jodi L. Pulizzi,Ardis A. Reed,Andrew S. Rhinehart,Linda M. Siminerio,Jing Wang
出处
期刊:Diabetes Care
[American Diabetes Association]
日期:2017-07-28
卷期号:40 (10): 1409-1419
被引量:274
摘要
By the most recent estimates, 30.3 million people in the U.S. have diabetes. An estimated 23.1 million have been diagnosed with diabetes and 7.2 million are believed to be living with undiagnosed diabetes. At the same time, 84.1 million people are at increased risk for type 2 diabetes. Thus, more than 114 million Americans are at risk for developing the devastating complications of diabetes (1).
Diabetes self-management education and support (DSMES) is a critical element of care for all people with diabetes. DSMES is the ongoing process of facilitating the knowledge, skills, and ability necessary for diabetes self-care, as well as activities that assist a person in implementing and sustaining the behaviors needed to manage his or her condition on an ongoing basis, beyond or outside of formal self-management training. In previous National Standards for Diabetes Self-Management Education and Support (Standards), DSMS and DSME were defined separately, but these Standards aim to reflect the value of ongoing support and multiple services.
The Standards define timely, evidence-based, quality DSMES services that meet or exceed the Medicare diabetes self-management training (DSMT) regulations, however, these Standards do not guarantee reimbursement. These Standards provide evidence for all diabetes self-management education providers including those that do not plan to seek reimbursement for DSMES. The current Standards’ evidence clearly identifies the need to provide person-centered services that embrace the ever-increasing technological engagement platforms and systems. The hope is that payers will view these Standards as a tool for reviewing DSMES reimbursement requirements and consider change to align with the way their beneficiaries’ engagement preferences have evolved. Research confirms that less than 5% of Medicare beneficiaries utilize their DSMES benefits (2,3). Changes in reimbursement policies stand to increase DSMES access and utilization, which will result in positive impact to beneficiaries’ clinical outcomes, quality of …
科研通智能强力驱动
Strongly Powered by AbleSci AI